Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
Hoppe
R T
RT
Department of Radiation Oncology, Stanford University Medical Center, CA 94305.
D000970:Antineoplastic Agents / Q000009:adverse effects; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D016609:Neoplasms, Second Primary / Q000209:etiology*; D011878:Radiotherapy / Q000009:adverse effects; D012306:Risk
D000970:Antineoplastic Agents